Calendar Barinthus Biotherapeutics plc

Equities

BRNS

US91864C1071

Market Closed - Nasdaq 04:30:00 2024-05-21 pm EDT 5-day change 1st Jan Change
2.151 USD -10.33% Intraday chart for Barinthus Biotherapeutics plc -7.27% -41.70%

Chart calendar Barinthus Biotherapeutics plc

046e166c0a4c8bb.rmIUEEnyDkLhdQSpgUEyHQ63KwFsa-QiWXE_vt6FIos.5yp3RzyGWzKvDVbs1w1xakmHfGgcPIsXLCle5-jpd8PkM1pjPLVDG75Eaw~e23115c0654f63389536561e31ea69e8

Upcoming events on Barinthus Biotherapeutics plc

2024-08-07 Q2 2024 Earnings Release (Projected)
2025-03-20 Q4 2024 Earnings Release (Projected)
2025-05-07 Q1 2025 Earnings Release (Projected)
2026-05-06 Q1 2026 Earnings Release (Projected)

Past events on Barinthus Biotherapeutics plc

2024-05-13 07:00 am Q1 2024 Earnings Release
2024-05-10 08:00 am Annual General Meeting
2024-03-20 08:15 am Q4 2023 Earnings Release
2023-09-20 02:00 pm Investor Meeting - Key Opinion Leader
2023-09-11 H.C. Wainwright Global Investment Conference
2023-08-10 08:00 am Q2 2023 Earnings Release
2023-06-20 European Association for the Study of the Liver Congress
2023-06-09 12:45 pm Jefferies Healthcare Conference
2023-06-01 American Society of Clinical Oncology Meeting
2023-05-22 A.G.P. Virtual Healthcare Conference
2023-05-12 08:00 am Q1 2023 Earnings Release
2023-05-11 08:00 am Annual General Meeting
2023-04-20 02:00 pm International Papillomavirus Conference
2023-03-24 08:06 am Q4 2022 Earnings Release
2023-03-12 Oppenheimer Healthcare Conference
2023-01-08 J.P. Morgan Healthcare Conference
2022-12-01 09:50 am Piper Sandler Healthcare Conference
2022-11-15 12:35 pm Jefferies London Healthcare Conference
2022-11-10 04:30 pm Q3 2022 Earnings Release
2022-11-07 01:00 pm American Association for the Study of Liver Disease Meeting - Abstract Number 38918

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
4,82


0,27
0,59
-54.54%
44,7
41,2
8.42%
0,80
1,07
-24.85%

0,00

EBITDA
Million USD
Released
Forecast
Spread
0,00


-44,6
-36,3
-22.92%
0,28
34,1
-99.17%
-78,5
-84,8
7.41%

-86,4

EBIT
Million USD
Released
Forecast
Spread
0,00


-45,2
-51,1
11.57%
-4,04
5,75
-170.31%
-83,9
-87,1
3.63%

-80,9

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-51,1
-48,3
-5.97%
0,85
7,77
-89.05%
-76,5
-81,3
5.86%

-82,1

Net income
Million USD
Released
Forecast
Spread
0,00


-50,9
-46,8
-8.58%
5,34
10,5
-49.2%
-73,3
-77,6
5.44%

-75,2

EPS
USD
Released
Forecast
Spread
-692


-1,96
-1,72
-13.84%
0,14
0,26
-45.74%
-1,91
-1,96
2.65%

-1,30

Announcement Date23/03/2125/03/2224/03/2320/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
15,0
3,71
305.34%
17,1
3,71
360.54%
6,17
8,00
-22.94%
6,46
3,25
98.68%
0,47
1,40
-66.57%
0,33
0,60
-44.33%
0,00
0,25
-
0,00
0,13
-
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
0,65
-11,7
105.59%
13,8
-14,7
193.62%
7,55
-12,0
162.94%
-26,0
-16,3
-60.22%
-21,5
-22,0
2.35%
-26,3
-22,9
-15.01%
-16,1
-21,8
25.95%
-20,0
-22,6
11.69%
-16,9
-24,6
31.31%

-19,0


-20,4


-21,4







Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
1,71
-11,6
114.71%
14,8
-14,7
200.77%
7,55
-12,0
162.89%
-23,2
-16,3
-42.66%
-18,7
-22,0
14.82%
-25,0
-22,9
-9%
-14,7
-24,2
39.2%
-18,1
-22,0
17.85%
-15,6
-24,6
36.82%

-21,0


-22,5


-23,0







Net income
Million USD
Released
Forecast
Spread
2,60
-11,6
122.32%
15,7
-14,7
207.03%
8,24
-12,0
168.68%
-21,2
-16,3
-30.39%
-18,2
-22,0
17.36%
-23,8
-22,9
-3.94%
-14,1
-21,0
32.99%
-17,3
-21,5
19.49%
-15,5
-24,6
37.1%

-21,0


-22,5


-23,0







EPS
USD
Released
Forecast
Spread
0,07
-0,31
121.94%
0,41
-0,32
226.84%
0,22
-0,33
166.13%
-0,55
-0,22
-152.68%
-0,48
-0,58
17.24%
-0,62
-0,55
-13.35%
-0,37
-0,52
28.5%
-0,45
-0,48
6.59%
-0,40
-0,54
25.74%

-0,45


-0,44


-0,47


-0,64


-0,61

Announcement Date11/05/2209/08/2210/11/2224/03/2312/05/2310/08/2309/11/2320/03/2413/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BRNS Stock
  4. Calendar Barinthus Biotherapeutics plc
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW